Leadership Team

Mike LaChance
Mike LaChanceChief Executive Officer
Mike LaChance brings extensive leadership experience from a career spanning two decades in the healthcare IT industry. He is well regarded for his strategic thinking, successful new market entry and execution, and relationship building – both internally and externally. Most recently, Mike served as EVP of Alliances & OEM Partnerships for Rhapsody. Mike joined Rhapsody from Vital Images where he was VP of Marketing & Business Development and led Vital’s entry into the Enterprise Image market, while also leading the acquisition of Karos Health.

Prior to that, Mike was the GM of Agfa Healthcare’s Cardiology business. During this time, he also served as President of Heartlab, an Agfa acquisition, and led its expansion across Agfa’s global footprint.

Mike earned a BSc in Mechanical Engineering from Notre Dame.

Jon Freeman
Jon FreemanChief Financial Officer
Jon Freeman has over 25 years of finance, operations, and management experience spanning several industries including medical technology, industrial manufacturing, and professional services. His experiential depth and diversity are further amplified by a notable range of work environments covering large public multi-national organizations to small, emerging private companies. Most importantly, Jon is well-recognized for creating real and substantial shareholder value throughout his career. His specific corporate experience includes: Fluke/Danaher, ev3/Covidien, Medafor (acquired by C.R. Bard), HistoSonics, and Gila Therapeutics.

Jon earned a B.A. in Economics from St. Olaf and an MBA from the University of Texas. He also holds a CFM designation from the Institute of Management Accountants.

Jeffrey Yu, MD
Jeffrey Yu, MDVice President and Chief Medical Officer
Dr. Jeffrey Yu is a board-certified radiologist and is also fellowship-trained and board-certified in nuclear medicine. In 2006, he was part of a small group that recognized there was a need to develop electronic sharing technology to help imaging specialists move patient imaging studies quickly, securely, and cost-effectively across the Hawaiian Islands.

Dr. Yu’s early research and development led to the BEAM solution which helped improve care and outcomes for stroke and trauma patients. In 2009, he started OneMedNet Corporation to commercialize the BEAM product. Since that time, Dr. Yu has remained an integral part of the strategic decision-making within OneMedNet.

Dr. Yu received his BS at U.C. Berkeley, MD at Wake Forest University, and completed his radiology residency and nuclear medicine fellowship at the Mallinckrodt Institute at Washington University.

Brian Frake, BSc, MSc and PhD
Brian Frake, BSc, MSc and PhDVice President, Product Development
Brian Frake has achieved a unique level of experience, and expertise, within the field of clinical imaging software. His area of responsibility has continually expanded during the last 20+ years. This progression has been due in large part to Brian’s significant contributions made on both the company and customer level.

Having worked in both software design (w/Siemens Healthcare) and clinical applications (w/GE Healthcare), Brian brings a strong user appreciation to product development. More recently, Brian held the position of Director of Clinical Applications for Vital Images (Toshiba Medical Systems) where he honed his leadership skills and clinical imaging proficiency in medical imaging, 3D image processing and imaging informatics. Brian brings OneMedNet a comprehensive background in DICOM data work flow, display and management.

Brian received BSc, MSc and PhD degrees in engineering mechanics and biomedical engineering from the Iowa State University.

Del Coufal
Del CoufalDirector of Marketing
Del Coufal has a unique blend of leadership experience in private and public organizations – covering both healthcare industry and healthcare provider environments. Key drivers for success include a strong business acumen and diverse operational exposure.

His executive experience started with a GM role for GE Healthcare’s Patient Monitoring Division, and was followed by a CEO position for Appleton Cardiology Associates, Ltd. Del then decided to focus his energies on commercializing impactful new medical technologies held by early stage companies. He led the marketing efforts as VP for both TomoTherapy, Inc. and Teramedica, Inc. TomoTherapy enjoyed the largest healthcare IPO of 2007, and TeraMedica was purchased by Fuji Medical in 2015.

Del has a B.S. in Biomedical Engineering from Duke University and an M.B.A. from the University of Michigan.

Board of Directors

Jeffrey Yu, MDDirector and Chairman
Jerry Hiatt, Esq.Director and Secretary
Erkan AkyuzDirector
Michael LaChanceDirector
Thomas Kosasa, MDDirector